Clinical Trial Update: Molecular Analysis of Gastric and OEsophageal Cancers STudy

View source ↗

Summary

A molecular analysis study of gastric and esophageal cancers has been withdrawn from clinical trials.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Adenocarcinoma
• Esophageal Squamous Cell Carcinoma
• Esophagogastric Junction Adenocarcinoma
• Gastric Adenocarcinoma

Snippet

Sponsor: Royal Marsden NHS Foundation Trust | Conditions: Adenocarcinoma Esophagus, Adenocarcinoma of the Stomach | Status: WITHDRAWN